• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Combination of alpha-interferon 2a (alpha-IFN 2a) and 13-cis-retinoic acid (13cRA) in recurrent, pre-treated squamous-cell carcinoma of head and neck (SCCHN).

作者信息

Toma S, Airoldi M, Palumbo R, Raffo P, Bumma C

机构信息

Department of Oncology, University of Genova, Italy.

出版信息

Int J Cancer. 1997 Feb 7;70(4):491-3. doi: 10.1002/(sici)1097-0215(19970207)70:4<491::aid-ijc23>3.0.co;2-h.

DOI:10.1002/(sici)1097-0215(19970207)70:4<491::aid-ijc23>3.0.co;2-h
PMID:9033664
Abstract
摘要

相似文献

1
Combination of alpha-interferon 2a (alpha-IFN 2a) and 13-cis-retinoic acid (13cRA) in recurrent, pre-treated squamous-cell carcinoma of head and neck (SCCHN).α-干扰素2a（α-IFN 2a）与13-顺式维甲酸（13cRA）联合用于复发性、经预处理的头颈部鳞状细胞癌（SCCHN）。
Int J Cancer. 1997 Feb 7;70(4):491-3. doi: 10.1002/(sici)1097-0215(19970207)70:4<491::aid-ijc23>3.0.co;2-h.
2
13-cis-retinoic acid plus interferon-alpha 2a in locally advanced squamous cell carcinoma of the cervix.
J Natl Cancer Inst. 1993 Mar 17;85(6):499-500. doi: 10.1093/jnci/85.6.499.
3
Efficacy of recombinant alpha-interferon 2a and 13-cis-retinoic acid in the treatment of squamous cell carcinoma.重组α-干扰素2a与13-顺式维甲酸治疗鳞状细胞癌的疗效
Ann Oncol. 1994 May;5(5):463-5. doi: 10.1093/oxfordjournals.annonc.a058881.
4
Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial.联合使用干扰素-α、13-顺式维甲酸和α-生育酚治疗局部晚期头颈部鳞状细胞癌：新型生物辅助性II期试验。
J Clin Oncol. 2001 Jun 15;19(12):3010-7. doi: 10.1200/JCO.2001.19.12.3010.
5
13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin.13-顺式维甲酸与干扰素α-2a：治疗晚期皮肤鳞状细胞癌的有效联合疗法。
J Natl Cancer Inst. 1992 Feb 19;84(4):235-41. doi: 10.1093/jnci/84.4.235.
6
A phase II study of 13-cis retinoic acid plus interferon alpha-2a in advanced stage penile carcinoma: an Eastern Cooperative Oncology Group study (E3893).13-顺式维甲酸联合干扰素α-2a治疗晚期阴茎癌的II期研究：东部肿瘤协作组研究（E3893）
Cancer Invest. 2003;21(1):41-6. doi: 10.1081/cnv-120016402.
7
Phase II trial of 13-cis-retinoic acid plus interferon-alpha in recurrent head and neck cancer.
Invest New Drugs. 1993 Feb;11(1):57-60. doi: 10.1007/BF00873912.
8
13-cis-retinoic acid and alpha-interferon in advanced squamous cell cancer of the oesophagus.13-顺式维甲酸与α-干扰素治疗晚期食管鳞状细胞癌
Eur J Cancer. 1997 Jan;33(1):165-6. doi: 10.1016/s0959-8049(96)00362-0.
9
Phase II study of a combination of low-dose cisplatin with 13-cis-retinoic acid and interferon-alpha in patients with advanced head and neck squamous cell carcinoma.低剂量顺铂联合13-顺式维甲酸和α干扰素治疗晚期头颈部鳞状细胞癌的II期研究
Anticancer Drugs. 1999 Apr;10(4):369-74. doi: 10.1097/00001813-199904000-00004.
10
13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix.
J Natl Cancer Inst. 1992 Feb 19;84(4):241-5. doi: 10.1093/jnci/84.4.241.